Literature DB >> 6831458

HLA antigens in renal cell carcinoma.

A F Kantor, J K McLaughlin, W A Blattner, F H Bach, W J Blot, L M Schuman, J F Fraumeni.   

Abstract

HLA antigen type was studied in 35 renal cell carcinoma patients who had bilateral disease, an early age of onset (less than age 45), or a family history of kidney cancer. Increased frequencies of the single-locus antigens HLA-DR8 (relative risk, 3.3) and HLA-Bw44 (relative risk, 2.1) and a deficit of HLA-DR1 (relative risk, 0.4) were found. Although based on small numbers, the relative excess was highest among persons phenotypically HLA-Bw44DR8. A higher frequency of the three-locus phenotype HLA-A3B7DR2 was also noted. The unusual HLA patterns were most pronounced among patients of German or Scandinavian origin, population groups reported to have an elevated risk of renal cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831458

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1 in total

1.  Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma.

Authors:  C Bain; Y Merrouche; I Puisieux; J Y Blay; S Negrier; V Bonadona; C Lasset; F Lanier; A Duc; L Gebuhrer; T Philip; M C Favrot
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.